On Patents | GenomeWeb

On Patents

There is little evidence for all the concern over gene patents hurting basic biomedical research, writes Timothy Caulfield at Science Progress. Caulfield, who studies health law and policy at the University of Alberta, says the justification makes logical sense and has some anecdotal evidence, but there is a lack of hard data. Furthermore, he says this debate overshadows the effect that "commercialization pressure" has on academic research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.